RU2426524C1 - Mud applicator - Google Patents

Abstract

FIELD: medicine.

SUBSTANCE: invention relates to field of mud-treatment, and can be applied with possibility of combination with electric and magnetic therapy, in carrying out therapeutic-preventive, as well as cosmetic procedures. Mud applicator contains mud sediments, packaged in envelope from non-woven material. Mud sediments contain particles with size not less than 0.5 mm. Envelope is made from non-woven thermally fastened material with surface density from 5 to 100 g/m² by connecting edges of non-woven thermally fastened cloth with value of connection cohesion not less than 0.1 N/cm².

EFFECT: simplification of technology of applicator use due to increased mechanical strength with simultaneous increase of impact of medicinal mud components on patient.

8 cl, 1 dwg, 2 ex

Description

The invention relates to medicine, namely to the field of mud therapy, and can be applied, including with the possibility of combination with electro- and magnetotherapy, during medical and preventive, as well as cosmetic procedures.

Curative muds are natural formations consisting of interconnected components: mud solution (liquid part), coarsely dispersed (core, skeleton) and finely dispersed (colloidal complex). Curative mud as a natural factor, due to its physicochemical properties, has a pronounced therapeutic effect.

As was experimentally established, in the organization of mud therapy, an essential condition is the preservation of the natural composition of the mud and giving it the necessary and convenient forms for the mud procedure. This is achieved by placing dirt in specific shells (containers). The material of the shell (capacity) to maintain the properties of the therapeutic mud must have sufficient characteristics to ensure that contact of the therapeutic mud with the environment (air, light, etc.) is excluded. The sheath material for imparting convenient forms to the mud should also have properties that provide the necessary contact of the patient’s body with the components of the therapeutic mud, and should not be torn under the influence of the gravity of the therapeutic mud even when wet, and also provide a combination of the use of mud therapy with electro- and magnetotherapy.

Known (RU, patent 2161947) is a container containing a container containing intended for application on the patient's body treatment mud. The specified container is made of elastic polymeric material in the form of a plate, the thickness of which is equal to the thickness of the application, moreover, a system of through channels is made in the plate. The healing mud is located in the system of through channels.

The disadvantage of the known container (applicator) should be recognized as the difficulty of filling it with therapeutic mud, as well as the insufficiently effective transfer of biologically active components of the therapeutic mud to the patient's body.

Known (DE, patent 3221647) is a container for conducting mud procedures of the extremities, comprising a body with a container for therapeutic mud and a device for reducing heat transfer mounted on the open part of the body, while the cavity between the walls of the body and the tank is filled with a working medium that maintains the temperature of the mud.

A disadvantage of the known container (applicator) should be recognized as a narrow scope, as well as insufficiently effective transfer of biologically active components of the therapeutic mud to the patient's body.

Known (RU, patent 2006219) is a container for conducting mud procedures of the extremities, comprising a body with a container for therapeutic mud and a device for reducing heat transfer mounted on the open part of the body, while the cavity between the walls of the body and the tank is filled with a working medium that maintains the temperature of the dirt, the body and capacity are made rigid in limb shape, the device for reducing heat transfer is made in the form of an elastic diaphragm, the body is equipped with a valve, and UUM. Preferably, the housing and the container are connected using stiffeners.

A disadvantage of the known container (applicator) should be recognized as a narrow scope, as well as insufficiently effective transfer of biologically active components of the therapeutic mud to the patient's body.

Known (RU, patent 2245129) is a mud applicator comprising a shell filled with therapeutic mud. In addition, it is equipped with a head, a step embedded in the cavity of the end of the front of the shell, a back, a step embedded in the cavity of the end of the rear of the shell, a limiter placed on the ledge of the back, a socket screwed into the threaded part of the back, two electrodes, one is installed in the head cavity and the other in the back cavity, with an electric wire located in the shell cavity on the longitudinal axis, one end connected to the electrode of the head and the other end to one of the terminals of the socket, the wire connecting the back electrode to Torah terminal socket and the cord, with a plug socket for connection to a current source, wherein the electrodes are arranged opposite each other and said electrically non-conductive is placed in the tube.

A disadvantage of the known applicator should be recognized as a narrow scope, as well as insufficiently effective transition of biologically active components of the therapeutic mud to the patient's body.

Known (DE, patent 264928) an applicator for mud therapy containing a tissue bag with therapeutic mud and a device for maintaining the temperature of the therapeutic mud during treatment.

A disadvantage of the known applicator should be recognized as an insufficiently effective transition of biologically active components of the therapeutic mud to the patient's body.

It was previously established (RU, patent 2306942) that it is desirable to pack silt-clay deposits (therapeutic mud) prepared for use in a shell of nonwoven materials. However, not all nonwoven materials can be used for packing silt-clay deposits.

The technical problem solved by using the developed design of the mud applicator is to improve its design.

The technical result obtained by implementing the developed design of the applicator consists in simplifying the technology of its use by increasing the mechanical strength while increasing the impact of the components of the therapeutic mud on the patient.

To achieve the specified technical result, it is proposed to use a mud applicator of a developed design.

The mud applicator contains mud deposits packed in a non-woven shell, the mud deposits containing particles no larger than 0.5 mm in size, the shell is made of non-woven thermally bonded material with a surface density of 5 to 100 g / m ² by connecting the edges of the non-woven thermally bonded cloth with the cohesion value of the compound is not less than 0.1 N / cm ² .

To preserve the properties of the applicator during storage and transportation, it is proposed to additionally use a shell made of polymer metallized, laminated, coated with a light and gas impermeable film layer with a thickness of 2-150 microns.

During the development of the technology for manufacturing mud applicators, it was found that the therapeutic mud of various deposits has fairly similar physicochemical characteristics - density, moisture content, acidity, etc., affecting the material of the applicator shell. Therefore, regardless of the place of origin of the packaged mud deposits, they can be packaged in the same container, shell. When selecting the material of the container, the shell from the set of non-woven materials known at the time of the work, it was found that this material must have a surface density of 5 to 100 g / m ² for full contact of the components of the mud deposits with the patient’s body. The indicated values of surface density provide the strength of the applicator shell when filling it with wet mud, transporting the applicator and its use with the maximum impact of the mud components on the patient. Since the material of the primary sheath of non-woven material is a web, it is necessary to fasten the edges of the web to form the desired shape of the applicator shell. It was found that, regardless of the bonding method, the cohesion of the resulting compound should be at least 0.1 N / cm ² . Otherwise, the connection may break under the action of the mass of mud deposits placed in the shell.

It is preferable to fill the applicator shell using homogenized (crushed, ground) mud deposits purified from foreign impurities. These deposits are known for their healing properties and have long been used in mud therapy. Although the homogenization (grinding, grinding) of mud sediments to obtain sediment particles no larger than 0.5 mm allows the active material to be obtained, it is preferable to homogenize (grind, grind) mud deposits to a particle size of not more than 0.3 mm or even less. Although the range of nonwovens with a surface density of 5 to 100 g / m ² ensures the performance of the mud applicator shell, it is still preferable, especially for applicators of significant volume (and mass), to use shells of nonwoven thermally bonded material with a surface density of 10 to 75 g / m ² .

It is preferable to use non-woven materials made of artificial and synthetic fibers. In particular, the sheath may be made of a non-woven thermally bonded material containing at least polyester fibers and / or viscose fibers and / or polypropylene fibers. In the most preferred, but not exclusive embodiment, a non-woven thermally bonded web may be used comprising both polyester fibers, viscose fibers and polypropylene fibers, and mixtures thereof. The edges of the membrane of the mud applicator can be connected by any method known in the art that does not allow leakage of mud deposits from the shell. In particular, for bonding the edges of the shell, bonding with glue, preferably based on a copolymer of ethylene with vinyl acetate with an adhesive capacity of at least 0.3 N / cm ^2, or by thermo-bonding its edges with the specified bonding strength, can be used.

Also, for storage and transportation, a shell made of a polymer (preferably polyethylene or polypropylene) film coated with a layer of light and gas impermeable material was used. This packaging option is mainly intended for transportation of crushed mud, as well as for vaginal mud therapy and for cosmetic use of therapeutic mud. Preferably, the film thickness is 20-150 microns. In the case of using such a package, it is a thermally bonded bag with a bond strength of at least 0.1 N / cm ² .

Homogenization (grinding, grinding) is preferably carried out in mills with a given millstone size. However, other options are possible. Advantageously, from 0.005 to 50 dm ^{3 of} homogenized (crushed, ground) mud deposits are placed in shells of the indicated type.

The drawing shows a section of the applicator, with the following notation: therapeutic mud 1, the shell 2 of non-woven material, the shell 3 of a polymeric material.

In a preferred embodiment, the mud applicator is made as follows.

Mud deposits extracted by any known method are mechanically cleaned of contaminating elements (plant branches, stones, industrial pollution, etc.). For this, a sampling of polluting elements manually or a screening system with predetermined mesh sizes can be used. These contaminants do not have a physiotherapeutic effect and interfere with subsequent homogenization (grinding, grinding).

After removing the contaminants, a mass of dirt is crushed, preferably on a screw shredder with grinding of natural mechanical impurities in mud deposits. In the process of processing mud deposits, other shredders can also be used.

The indicated natural mechanical inclusions include the remains of algae, crustacean shells, salt crystals, sand, etc.

Mud deposits containing crushed natural mechanical impurities are fed to a mill mill for homogenization (grinding) (any type of homogenizers (grinders) can be used to obtain particles of mud deposits of about 0.3 mm in size). Due to the previously established gap between the millstones, particles of mud deposits of the required size are obtained.

Homogenized (crushed) mud deposits are placed in containers, shells corresponding to the characteristics given in the claims.

After filling the applicator shell with homogenized (crushed) therapeutic mud or a mud applicator without a shell, it is necessary to isolate the surface of the therapeutic mud from contact with the external environment. For this purpose, a filled applicator shell or a mudless applicator without a shell is placed in a light- and gas-tight additional shell, a container (for example, polymer films laminated with aluminum foil).

It was experimentally established that the use of homogenized (crushed) to a particle size of not more than 0.5 mm therapeutic mud with crushed large mechanical inclusions significantly increases the physiotherapeutic effect of the application by increasing the area of interaction of active substances with the skin or mucous membrane of the patient.

In the future, the nature and advantages of the developed method for producing applicators will be disclosed using implementation examples. The studies were conducted in the State Institution "Stavropol Regional Hospital for War Veterans" in 2008-2009. on 34 patients who volunteered for treatment. Patients were admitted with various diseases of the musculoskeletal system.

1. Patient I., 42 years old. Diagnosis: polyarthritis, a slowly progressing course, R-stage II stage, activity I-II stage, FSB-2a. Complaints of pain in the knee, elbow joints, as well as in the joints of the right hand, stiffness in the morning. Sick for about 9 years, when a swelling appeared in the left knee joint, the temperature rose. After treatment - remission. Exacerbation after 2 years, when both knee and ankle joints were involved in the process, despite treatment, remission was not achieved. Upon admission to the clinic - proliferative changes in the ankle and right knee joints, exudative - in the left (2 points). ESR - 13 mm / h, GB - 124 g / l, sialic acids - 230 units, S-RB - 1, RF - 17 KS - 19.3 μmol / s, CEC - 30 units, lysozyme - 9 μg / ml, IgG - 18.29, IgA - 2.52, IgM - 1.69 mg / ml. ECG - impaired repolarization in the anterior septal department.

The patient received mud applications using developed applicators using homogenized (ground) dirt on both knee and both elbow joints, as well as on the right hand. The temperature of the preheated mud was 38-39 ° C, the exposure time of 15 minutes every other day, 10 procedures. The treatment was easily tolerated, pain in the joints and stiffness disappeared, proliferative changes in the ankles, in the left knee joints decreased, the effusion decreased from 2 to 1 point, joint mobility improved. ESR - 2 mm / h, GB - 120 g / l, sialic acids - 200 units, S-RB - 0, RF - 0, 17 CS - 20.1 μmol / s, CEC - 10 units, lysozyme - 3 5 μg / ml, IgG - 15.3, IgA - 2.41, IgM - 1.69 μg / ml. ECG is a normal variant.

Thus, after the course of treatment, a positive clinical effect was noted, including in the joint with exudative changes, the activity of the inflammatory and immunological process decreased, and the ECG normalized.

At the same time, a study was conducted of the influence of the parameters of the applicator shell made of non-woven material on the achievement of the specified technical result.

During the study, it was found that when using non-woven material with a surface density of less than 5 g / m ² for any particle size of the treatment mud, when transferring the applicator from the shipping container to the patient’s body, the wet non-woven fabric is torn, which makes it difficult to use the applicator.

When using non-woven material with a surface density of 5 g / m ² to 100 g / m ² for any particle size of the treatment mud, when transferring the applicator from the shipping container to the patient’s body, the wet non-woven fabric does not break, as in the mud treatment. With the indicated range of surface density of the nonwoven material, the maximum therapeutic effect is achieved, especially when using dirt particles with a size of not more than 0.5 mm, due to the free passage of biologically active components of the therapeutic mud to the patient's body.

When using non-woven material with a surface density of more than 100 g / m ² with any particle size of the treatment mud, when transferring the applicator from the shipping container to the patient’s body, the wet non-woven fabric does not break, as in the mud treatment. But with the indicated range of surface density of the nonwoven material, the therapeutic effect is weakened due to the difficulty of passage of biologically active components of the therapeutic mud to the patient's body.

Using the connection of the edges of a nonwoven thermally bonded fabric with a cohesion value of the compound of less than 0.1 N / cm ^2, regardless of the method of bonding the edges, when transferring the applicator from the transport container to the patient’s body, the membrane ruptures along the seam and, in fact, destroys the applicator.

Using the connection of the edges of the non-woven thermally bonded fabric with a cohesion value of the compound of at least 0.1 N / cm ² regardless of the method of bonding the edges ensures the strength of the shell regardless of the size of the particles of the therapeutic mud and the mass of the applicator.

When treating patients using applicators known from the prototype solution, the overall effectiveness was lower, especially in the presence of signs of exudative inflammation in the joints, cardiovascular pathology, and immune disorders. We give one of the observations.

Example 2. Patient P., 24 years old. Diagnosis: Oligoarthritis, seronegative, slowly progressive course, R-stage II stage, activity I, FSB - 2b. Complaints of pain in the joints, stiffness in the morning for 30 minutes, limitation of mobility in the joints of the arms and legs. Sick for 4 years, the onset of the disease - after a sore throat with fever, swelling of the knee joints. After a year, the disease worsens with the involvement of the ankle joints, small joints of the hands, and wrist. ESR - more than 40 mm / h. Treated with prednisone and then NSAIDs. Contractures of large joints of the arms and legs developed. Upon admission to the clinic, contracture of all major joints (except the shoulder and wrist) with a predominance of proliferative-fibrous changes, an increase in local temperature (1 point) over the right knee joint. ESR - 12 mm / h, GB - 110 g / l, CA / G - 1.3, sialic acids - 200 units, S-RB - 0.5 units, RF - 0.5 units, OP - 1 7, HSC - 0.037, 17 CS - 22.4 μmol / s, CEC -30 units, lysozyme - 9 μg / ml, IgG - 18.4, IgA - 2.4, IgM - 1.72 mg / ml . ECG - sinus bradycardia.

The patient was treated with developed mud applicators applied to the knee and ankle joints at 38-39 ° C, 15 minutes, every other day, 10 procedures with additional massage of the joints. The treatment was easily transferred, joint pain decreased, stiffness in the morning less pronounced, more free in movement in the joints. At the same time, the temperature above the right knee joint increased by 0.8 ° C and the pain in it during palpation increased. ESR - 10 mm / h, GB - 106 g / l, sialic acids 220 units, S-RB - 2 units, RF - 0.5 units, 17 CS - 20.6 μmol / s, CEC - 30 units ., LIZ - 14 μg / ml, IgG - 18.8, IgA - 2.55, IgM - 1.82 mg / ml. ECG - sinus tachycardia, impaired repolarization processes in the anterolateral wall of the left ventricle.

Thus, subjectively, the patient's condition improved, but exudative manifestations in the joint became more pronounced, activity indicators increased, ECG worsened, the immunological status did not change.

Treatment according to the proposed methodology (6 procedures) was performed in 16 patients with various forms of arthritis diseases (main group), in the control group (10 procedures - prototype) there were 18 patients. Groups are representative by gender, age, duration of disease, and severity of the process.

The treatment using the developed mud applicators was successful for 13 patients of the main group, 2 patients felt a slight improvement, 1 without a change in condition. In the control group for 12 patients, treatment was successful, 4 patients felt improvement, 2 without any change in condition.

Similar studies with similar results were carried out in the case of gynecological diseases, urological diseases, as well as diseases of the oral cavity.

Additionally, studies have been conducted on the effect of materials included in the applicator shells on the achievement of the specified technical result. Significant influence of the composition of the fibers that make up the nonwoven fabric is not revealed.

Therefore, the use of developed mud applicators has a more effective therapeutic effect. It can be assumed that the active substances that passed through the shell to the skin also remain on the patient’s body surface for a longer time, which also contributes to a more effective treatment. It was also experimentally established that the use of an additional light- and gas-tight casing also contributes to an increase in the effectiveness of treatment by preserving the useful components of the mud during heating, as well as during the storage of dirt.

Claims (8)

1. A mud applicator containing mud deposits packaged in a shell of non-woven material, characterized in that the mud deposits contain particles no larger than 0.5 mm, the shell is made of non-woven thermally bonded material with a surface density of from 5 to 100 g / m ² by connecting the edges of a non-woven thermally bonded web with a cohesion value of the compound of at least 0.1 N / cm ² . 2. The mud applicator according to claim 1, characterized in that for storage and transportation it is additionally placed in a shell made of polymer metallized, laminated, coated with a light and gas impermeable film layer with a thickness of 10-150 microns. 3. The applicator according to claim 1, characterized in that the mud deposits contain particles no larger than 0.3 mm in size. 4. The applicator according to claim 1, characterized in that the primary shell is made of non-woven thermally bonded material with a surface density of from 10 to 75 g / m ² . 5. The applicator according to claim 1, characterized in that the primary sheath is made of non-woven thermally bonded material containing at least polyester fibers and / or viscose fibers and / or polypropylene fibers. 6. The applicator according to claim 5, characterized in that used non-woven thermally bonded fabric containing polyester fibers, viscose fibers and polypropylene fibers and mixtures thereof. 7. The applicator according to claim 1, characterized in that the shell is made of non-woven thermally bonded material, the edges of which by bonding with an adhesive based on a copolymer of ethylene with vinyl acetate with an adhesive capacity of at least 0.3 N / cm ² . 8. The applicator according to claim 1, characterized in that the shell is made of non-woven thermally bonded material by thermally connecting its edges.

Images